Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Earnings release
confidence 98%
filed 2026-08-19
EX-99.1
This is a press release announcing iQIYI's unaudited financial results for the second quarter ended June 30, 2026. The document discloses total revenues of RMB6.29 billion (down 5% YoY), operating loss of RMB104.8 million, and net loss attributable to iQIYI of RMB287.5 million. It includes detailed financial statements (income statement, balance sheet) and management commentary on performance. This is a discrete earnings announcement, not a periodic financial report filing, and the results are material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 75%
filed 2026-08-19
SK hynix's board approved acquisition of 24,070,000 common shares (approximately 3.3% of outstanding shares) for an estimated aggregate value of ₩40 trillion, with the stated purpose of "improvement of shareholder value through cancellation of treasury shares." While technically a share repurchase program, the explicit intent to cancel the shares and return capital to remaining shareholders aligns with the economic substance of a dividend distribution or return of capital. The materiality and scale (₩40 trillion) would affect a reasonable investor's assessment of capital allocation and shareholder returns.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 85%
filed 2026-08-19
SK hynix announces a shareholder return policy committing to return over 50% of cumulative Free Cash Flow (2025–2027) through both treasury share acquisitions (approximately Won 40 trillion) and cash dividends, with plans to expand dividends including special dividends. This is a material capital allocation and shareholder distribution announcement that would affect investor assessment of the company's financial strategy and shareholder value creation.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 75%
filed 2026-08-19
SK hynix's board approved cancellation of 24,070,000 treasury shares (approximately 3.3% of issued shares) with an estimated aggregate value of ₩40 trillion on August 19, 2026. Share cancellation is a form of capital return to shareholders that reduces the share count and increases earnings per share, functionally equivalent to a special dividend or return of capital. The materiality and scale (₩40 trillion cancellation value) would affect a reasonable investor's assessment of capital allocation and per-share metrics.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-08-19
EX-99.1
The exhibit announces a 1-for-20 reverse split of XCHG's American depositary shares (ADS Ratio change from 1:40 to 1:800), effective August 21, 2026. This is a capital structure modification affecting all ADS holders and trading mechanics on Nasdaq under ticker XCH. While not a traditional governance event (board, executive, or shareholder vote), it is a material structural change to the company's securities that would affect investor holdings and trading price, warranting classification as a governance-related capital action.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-19
Item 5.02
The disclosure centers on new Executive Employment Agreements entered into on August 17, 2026 with Dr. Yuichi Iwaki (President and CEO) and Dr. Kazuko Matsuda (Chief Medical Officer). The filing details compensatory arrangements including base salaries ($690,246 for Dr. Iwaki; $540,143 for Dr. Matsuda), annual incentive bonuses (55% and 40% of base salary respectively), severance protection terms, equity acceleration provisions, and change-of-control benefits. These are material modifications to executive compensation and severance arrangements that would affect investor assessment of the company's obligations and executive retention.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-19
Item 8.01
Northern Oil & Gas announced a proposed private offering of $500 million in senior notes due 2034, with net proceeds intended to repay revolving credit facility borrowings and for general corporate purposes. This is a material creation of a new direct financial obligation under Item 2.03 (or disclosed under Item 8.01 as Other Events). The $500 million principal amount and use of proceeds make this material to investors assessing the company's capital structure and liquidity.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-08-19
Item 3.01
Mereo received a second notice from Nasdaq on August 18, 2026, indicating failure to maintain the minimum $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2). While the company has been granted an additional 180-day compliance period until February 16, 2027, the disclosure explicitly states that failure to regain compliance will result in delisting. This is a classic delisting-risk disclosure under Item 3.01, materially affecting the company's continued listing status and investor confidence.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-08-19
Item 5.02
Nathan Tucker was appointed as Senior Vice President and Chief Financial Officer of Core Natural Resources, Inc. effective August 18, 2026, succeeding Mitesh Thakkar who expanded into an additional role. This C-suite appointment is material to investor assessment of company leadership and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-19
Item 5.02
Baxter International appointed John Rogers as Executive Vice President and Chief Financial Officer, effective October 1, 2026. Rogers' compensation package includes a base salary of $925,000, target bonus of 100% of base, equity grants totaling $4,000,000 LTI target value, and a sign-on bonus of $2,827,629.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 82%
filed 2026-08-19
Item 1.01
Marvell issued a warrant to Google for up to 58,970,907 shares of common stock at $206.58 per share in connection with a commercial agreement for custom semiconductor products. The warrant vests over time based on time-based tranches and discretionary purchases through fiscal 2033, creating significant dilution potential. This unregistered equity issuance under Section 4(a)(2) exemption represents a material dilutive event affecting shareholder ownership and capital structure.
View raw filing on EDGAR →
6-K
Other material
confidence 75%
filed 2026-08-19
The 6-K announces the imminent expiration of ReNew Energy's warrants (RNWWW) on August 22, 2026, with trading suspension on August 21, 2026, and subsequent delisting from Nasdaq. While warrant expiration is a capital-structure event affecting security holders, it does not fit neatly into the standard taxonomy categories (not a dilutive issuance, debt issuance, dividend, or delisting risk per se—the delisting is a consequence of warrant expiration, not a compliance failure). The event is material to warrant holders and investors tracking the company's capital structure, warranting classification as a material event outside the named categories.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-08-19
Item 1.01
The Company entered into a sixth amendment to its Loan and Servicing Agreement on August 13, 2026, which modified key terms of an existing credit facility. While this is technically an amendment rather than a new debt issuance, the disclosure centers on material changes to a direct financial obligation—increased Advance Rates, reduced Aggregate Commitments from $200.0 million to $185.0 million, modified Concentration Limits, and an extended Scheduled Maturity Date from June 30, 2028 to July 3, 2029. These modifications to the credit facility structure are most closely aligned with debt_issuance (creation or amendment of a credit facility), though covenant_breach could apply if the amendment was triggered by a default; the filing does not indicate a breach, so debt_issuance is the better fit.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-08-19
The 6-K announces the closing of an initial public offering of 4,285,714 ADSs representing 21,438,570 ordinary shares on August 19, 2026. While technically an IPO is a registered offering (not an unregistered private placement), it represents a material dilutive issuance of equity that creates a new class of public shareholders and fundamentally alters the company's capital structure. This is a material event affecting investor assessment of ownership and control.
View raw filing on EDGAR →
6-K
Earnings release
confidence 15%
filed 2026-08-19
This is not an earnings release. The 6-K announces the closing of an initial public offering (IPO) of 4,285,714 ADSs and resumption of trading on NYSE under ticker FOIL. This is a capital-raising and listing event, not a financial results disclosure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-19
Item 3.02
Stepstone Private Credit Fund LLC completed an unregistered sale of 1,134,111 LLC interests for $29.5 million pursuant to subscription agreements under Section 4(a)(2), Regulation D, and Regulation S exemptions.
View raw filing on EDGAR →
8-K
Financial Other
confidence 65%
filed 2026-08-19
Item 8.01
The Company disclosed its net asset value per share ($26.02 as of July 31, 2026), aggregate NAV ($3,021.8 million), investment portfolio fair value ($4,007.7 million), debt outstanding ($1,490.9 million), and ongoing private offering status ($2,930.1 million raised toward a $10 billion target).
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-08-19
The 6-K discloses a one-for-40 reverse stock split of C3is Inc.'s common stock, effective August 18, 2026, reducing outstanding shares from approximately 57.6 million to 1.44 million. While a reverse split is a governance/capital structure action rather than a discrete operational or financial event, it is material to investors as it fundamentally alters share count, exercise prices of warrants, and conversion prices of preferred stock, and affects trading on Nasdaq. This is a governance action that does not fit the specific named categories (exec appointment/departure, compensation, shareholder vote results, etc.) but clearly falls within governance domain.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-08-19
Item 8.01
Korro Bio announced submission to the Australian Alfred Health Human Ethics Committee to initiate a Phase 1/2 clinical trial for KRRO-121, a GalNAc-conjugated RNA editing oligonucleotide for hyperammonemia treatment. This is a material operational and clinical development milestone for a biopharmaceutical company—the initiation of first-in-human trials represents a significant advancement in the drug development pipeline that would affect a reasonable investor's assessment of the company's progress and prospects, though it does not fit the specific categories of earnings, M&A, impairment, or other defined event types.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-19
EX-99.1
This is a Q2 2026 earnings announcement for Sunrise Communications AG disclosing quarterly financial results including revenue (CHF 712.9M), Adjusted EBITDAaL (CHF 244.4M), and Adjusted Free Cash Flow (CHF 204.4M), along with operational metrics (mobile postpaid net adds of +21,000, Internet net adds of +3,000) and a reconfirmed 2026 financial guidance. The document is explicitly titled an "ad hoc announcement" containing consolidated Q2 and H1 2026 results with detailed financial tables and management commentary from CEO André Krause.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-19
Item 3.02
Apollo Debt Solutions BDC sold 337,710 unregistered Class I Common Shares for $8,047,437 to feeder vehicles, relying on Section 4(a)(2) and Regulation S exemptions from Securities Act registration. This unregistered equity issuance represents a significant capital raise and dilutes existing shareholders.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-19
Item 7.01
Apollo Debt Solutions BDC declared distributions for each class of common shares on August 19, 2026, with a gross per-share amount of $0.1800 for all classes (varying net amounts after fees), payable to shareholders of record as of August 31, 2026, and to be paid on or around September 29, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-19
Item 2.02
The filing discloses John B. Sanfilippo & Son, Inc.'s financial results for fiscal 2026 fourth quarter and full year ended June 25, 2026, via a press release attached as Exhibit 99.1. The disclosure includes net sales of $1.18 billion (up 6.2%), diluted EPS of $5.26 (up 4.6%), and detailed quarterly and annual financial statements, which are material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-19
Item 2.02
This is a standard earnings release disclosing Jaguar Health's second quarter 2026 financial results, including revenue, operating losses, and key operational metrics. The filing explicitly states "Jaguar Health, Inc. (the 'Company') issued a press release announcing the second quarter 2026 results" and furnishes the press release as Exhibit 99.1, which is the typical structure for Item 2.02 earnings disclosures. The material includes detailed financial highlights, revenue breakdowns by product line, and expense analysis for Q2 2026 versus Q2 2025.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-19
EX-99.1
This is a press release announcing Full Truck Alliance's unaudited financial results for the second quarter ended June 30, 2026. The exhibit discloses quarterly net revenues of RMB3,381.6 million (up 4.4% YoY), net income of RMB1,345.1 million (up 6.3% YoY), operational metrics (fulfilled orders, MAUs), and forward guidance for Q3 2026. The disclosure includes detailed financial and operational highlights, management commentary, balance sheet and cash flow information, and a quarterly dividend declaration. This is a standard earnings release event material to investors assessing the registrant's financial performance and operational trajectory.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-19
Item 1.01
Newell Brands issued $600 million of 6.250% senior notes due 2031 on August 19, 2026, pursuant to an Indenture with U.S. Bank Trust Company. The company intends to use proceeds to redeem outstanding 2027 Notes, pay fees, and repay revolving credit facility borrowings.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-08-19
Item 1.01
FrontView REIT entered into an Amended and Restated Distribution Agreement authorizing the sale of up to $125.0 million in common stock through an at-the-market (ATM) offering program with multiple sales agents and forward purchasers. With $50.7 million already sold and $74.3 million remaining available, this represents a substantial dilutive equity issuance mechanism. The inclusion of forward sale agreements (both contingent and non-contingent) further amplifies the dilutive potential. This is a classic ATM offering disclosure under Item 1.01, material to equity investors due to the significant authorized dilution.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-19
Item 8.01
Northern Oil & Gas announced the pricing of a $500 million private offering of 7.500% senior notes due 2034. This is a material creation of a new direct financial obligation. The company intends to use proceeds to repay revolving credit facility borrowings and for general corporate purposes, representing a significant capital structure event for the registrant.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-08-19
Item 8.01
The disclosure centers on Digital Realty's acquisition of Columbia Capital, with the Company registering resale of shares issued as consideration in the transaction. While the Item 8.01 filing focuses on the registration mechanics, the underlying event is the material acquisition itself. The reference to shares "issued as consideration in the transaction" confirms the M&A activity is the salient event, even though the prose emphasizes the prospectus supplement filing.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-08-19
Item 1.01
Korn Ferry entered into an amended and restated credit agreement on August 18, 2026, establishing a $600 million senior secured term loan facility and continuing an $850 million revolving credit facility. The company borrowed the full principal amount of the Term Loan Facility on the effective date, with proceeds used to fund a redemption of $400 million in 4.625% Senior Notes due 2027, pay transaction fees, and finance a portion of a pending acquisition.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-19
Item 3.02
TuHURA Biosciences issued 1,878,287 unregistered shares of common stock to Parkview Holdings as a fee for a $50 million revolving credit facility, relying on Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-19
Item 5.07
TuHURA Biosciences held its 2026 Annual Meeting of Stockholders on August 18, 2026, with all six proposals passing by requisite majorities: election of six directors (James Bianco, James Manuso, Alan List, George Ng, Robert E. Hoffman, and Craig Tendler), approval of Nasdaq-required share issuance, advisory vote on executive compensation, say-on-frequency vote, auditor ratification, and adjournment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 90%
filed 2026-08-19
Item 5.02
Scott Gleason was appointed as Chief Financial Officer and Treasurer effective August 31, 2026, with a base salary of $400,000, a $500,000 equity award, and a 40% bonus target. Gleason brings 25+ years of healthcare and capital markets experience to the role.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-19
Item 5.02
The Compensation Committee approved and granted restricted stock awards to the CEO (James Rolke, 208,076 shares) and CFO (Chester S. Zygmont, III, 208,073 shares) effective August 17, 2026, pursuant to the 2021 Equity Incentive Plan. This is a direct disclosure of compensatory arrangements for named executives with specific vesting conditions tied to market capitalization milestones and time-based tranches, which is the core definition of exec_compensation under Item 5.02(e).
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-19
Item 1.01
The filing discloses an amendment to an Agreement and Plan of Merger between DXL and FBB Holdings I, Inc., extending the end date from September 11, 2026 to October 30, 2026. This is a material acquisition/merger activity under Item 1.01, as it modifies the terms of a previously disclosed definitive merger agreement and directly affects the timeline and status of the proposed transaction.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-08-19
Item 8.01
Ultragenyx announced FDA accelerated approval for GENGLYCOS (DTX401) for glycogen storage disease type Ia, a significant regulatory and commercial milestone for the company's pipeline. This is a material operational/strategic event—the approval of a novel gene therapy product—that does not fit the specific categories of earnings release, M&A, or other named event types. The disclosure includes clinical trial data supporting the approval and post-marketing study commitments, indicating a major product advancement that would affect investor assessment of the company's prospects.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-19
Item 5.07
CalciMedica held its Annual Meeting on July 23, 2026, and shareholders voted on eight proposals including director elections, auditor ratification, an equity plan amendment increasing authorized shares by 7.5 million, say-on-pay votes, a reverse stock split, and two material warrant issuances involving up to approximately 37.3 million shares of potential dilution.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-08-19
The 6-K discloses the closing of a private placement offering on August 17, 2026, in which Zeta Network Group issued 3,412,970 Class A ordinary shares and 3,412,970 warrants to investors for aggregate gross proceeds of US$10,000,002.10. The securities were unregistered and sold pursuant to Section 4(a)(2) and Regulation S exemptions, constituting a dilutive equity issuance material to investors assessing the company's capital structure and ownership.
View raw filing on EDGAR →
8-K
Governance Other
confidence 72%
filed 2026-08-19
Item 1.01
The disclosure describes entry into lock-up agreements with executive management holding ~54% of outstanding shares and ~66% of non-publicly traded shares, extending the original IPO lock-up period by six months until February 23, 2027. While Item 1.01 typically covers M&A or material commercial agreements, this is a governance/capital-structure matter involving voluntary restrictions on insider share sales following an IPO. The materiality stems from the substantial insider ownership affected and the signal it sends about management confidence and insider trading risk management post-IPO.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-19
Item 7.01
AIB Data Centers released an investor presentation on August 19, 2026 disclosing its business strategy, operational pipeline, financial position, and growth trajectory. The presentation details the company's 'power-first' data center development model, contracted and identified capacity across six active sites (65 MW contracted, ~570 MW identified), management team credentials, and Q2 2026 financial results including $2.9M revenue and adjusted EBITDA of $(3.1)M.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-19
EX-99.1
This is a press release dated August 19, 2026, disclosing Marti's second quarter 2026 financial results. The document presents revenue of $20.0 million (up 141% YoY), gross profit margin of 77%, positive Adjusted EBITDA of $2.9 million for the first time, and increased full-year 2026 guidance to $85 million revenue and $7 million Adjusted EBITDA. These are discrete quarterly financial results announced to the market, making this a classic earnings release event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-19
Item 5.07
This is a clear disclosure of shareholder vote results from the August 18, 2026 annual meeting under Item 5.07. The filing reports voting outcomes for five proposals: election of six directors (Proposal 1), ratification of auditor dbbmckennon (Proposal 2), approval of the 2026 Equity Incentive Plan (Proposal 4), and approval of adjournment authority (Proposal 5), with Proposal 3 (Charter Amendment) deferred to September 16, 2026 due to insufficient votes. The detailed vote tallies for each proposal and director candidate are provided, making this a standard shareholder vote results disclosure material to investors assessing governance and capital allocation decisions.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 85%
filed 2026-08-19
The Company announced an ADS ratio change (1-for-10 reverse split) effective August 21, 2026, explicitly to "regain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per ADS for continued listing." The disclosure acknowledges that the Company's stock price had fallen below the minimum bid price threshold and that there is no assurance the reverse split will restore compliance. This is a material delisting-risk disclosure under Item 3.01 equivalent, as it signals the registrant's failure to satisfy a continued listing rule and the remedial action taken.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-19
Item 5.02
Jimmy D. Ford was appointed as a Class III director on August 17, 2026, by the Class B Shareholders, with a term expiring at the 2029 annual meeting. He was also appointed to serve on the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 85%
filed 2026-08-19
The 6-K discloses the outcome of an Extraordinary General Meeting held on August 18, 2026. Although no resolutions were voted upon due to failure to achieve the required quorum (one-half of issued and outstanding voting shares), the disclosure of a failed EGM and the Board's decision not to adjourn it constitutes a shareholder-vote-related event. The failure to achieve quorum and the Board's decision to conclude the meeting without adjournment are material governance outcomes that would affect investor assessment of the Company's ability to conduct shareholder business.
View raw filing on EDGAR →
6-K
Exec departure
confidence 75%
filed 2026-08-19
The report discloses the resignation of Mr. Shihua Li as a director and Audit Committee Chairperson, and Ms. Yee Hing Wan as Chief Financial Officer, both effective immediately on August 15, 2026. While the report also announces the appointment of replacements, the principal disclosed action is the departure of two officers, including the CFO. Both resignations are stated to be without disagreement or claims, but the simultaneous departure of the CFO and a key board member is material to investor assessment of governance and continuity.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-08-19
Item 4.01
The filing discloses the dismissal of WithumSmith+Brown, PC as the Company's independent registered public accounting firm effective immediately on July 30, 2026, and the concurrent appointment of Victor Mokuolu, CPA PLLC as the new auditor. This is a classic auditor change under Item 4.01. While the prior auditor's going-concern qualification is noted, the principal disclosed action is the change in auditors themselves, making auditor_change the most salient classification.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-08-19
Item 5.03
CleanCore Solutions, Inc. announced a corporate name change to Zone Frontier Inc., effective August 31, 2026, reflecting a strategic pivot from cleaning services to AI infrastructure. The name change was filed as a Certificate of Amendment to the Articles of Incorporation with Nevada's Secretary of State, with no stockholder vote required. The ticker symbol remains 'ZONE.'
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-08-19
Item 8.01
The Fund issued $750 million aggregate principal amount of 6.200% notes due 2031 on August 19, 2026, creating a new direct financial obligation. The disclosure details the terms, maturity date, interest rate, ranking, covenants, and redemption provisions of the notes, which is the hallmark of a debt issuance event. This is material to investors as it represents a significant capital raise and increases the Fund's leverage.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-19
Item 8.01
The filing discloses the confidential submission of a draft Form S-4 registration statement relating to a business combination between SVAQ and EigenQ, a quantum technology company. The disclosure explicitly states this is a "proposed business combination transaction" previously announced on June 17, 2026, and represents a material acquisition/change of control event. The transaction is expected to close in Q4 2026 and will result in EigenQ becoming a publicly traded company under the name EigenQ Holdings, Inc., trading on Nasdaq under ticker "EIGQ"—a clear indicator of a material M&A activity requiring shareholder approval.
View raw filing on EDGAR →